These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7082549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pizotifen in the management of migraine.
    Bademosi O, Osuntokun BO.
    Practitioner; 1978 Feb; 220(1316):325-7. PubMed ID: 345259
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Toleration and effectiveness of pizotifen in migraine.
    Mikropoulos HE.
    Res Clin Stud Headache; 1978 Feb; 6():167-72. PubMed ID: 725252
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Etiology and treatment of migraine].
    Petelin LS, Shtok VN, Pigarev VA.
    Sov Med; 1976 Nov; (11):62-5. PubMed ID: 1006395
    [No Abstract] [Full Text] [Related]

  • 8. Pizotifen in the treatment of migraine.
    Heathfield KW, Stone P, Crowder D.
    Practitioner; 1977 Mar; 218(1305):428-30. PubMed ID: 322111
    [No Abstract] [Full Text] [Related]

  • 9. Antiserotonin agents in the treatment of migraine.
    Prusiński A, Klimek A.
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):189-93. PubMed ID: 1107969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preventive treatment of migraine using a new antimigraine drug Sandomigran].
    Klapetek J.
    Cesk Neurol Neurochir; 1976 Jan; 39(1):28-35. PubMed ID: 1253301
    [No Abstract] [Full Text] [Related]

  • 12. [Value of Sanmigran in treatment of so called digestive migraine].
    Chevrel B.
    Med Chir Dig; 1976 Jan; 5(3):167-70. PubMed ID: 1004048
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine.
    Havanka-Kanniainen H, Hokkanen E, Myllylä VV.
    Cephalalgia; 1987 Mar; 7(1):7-13. PubMed ID: 3555838
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A retrospective study to assess the migraine headache remission rate after cessation of pizotifen therapy.
    Capildeo R, Wimalaratna HS, Bosley E, Shah SN.
    Br J Clin Pract; 1990 Dec; 44(12):622-6. PubMed ID: 2102160
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Significance of the contribution of pizotifen in correcting appetite disorders and weight insufficiencies].
    Blouza Chachoub S, Achour A, Ben Mansour A, Fareh N, Nagati K, Kallal Z.
    Tunis Med; 1989 Mar; 67(3):207-12. PubMed ID: 2756581
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.